[go: up one dir, main page]

ES471572A1 - Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica - Google Patents

Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica

Info

Publication number
ES471572A1
ES471572A1 ES471572A ES471572A ES471572A1 ES 471572 A1 ES471572 A1 ES 471572A1 ES 471572 A ES471572 A ES 471572A ES 471572 A ES471572 A ES 471572A ES 471572 A1 ES471572 A1 ES 471572A1
Authority
ES
Spain
Prior art keywords
polypodium
polar solvent
decumanun
rhyzomes
linn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471572A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CONRAD Ltd
Original Assignee
CONRAD Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES471572A priority Critical patent/ES471572A1/es
Application filed by CONRAD Ltd filed Critical CONRAD Ltd
Priority to AR274971A priority patent/AR230188A1/es
Priority to GR57991A priority patent/GR65334B/el
Priority to DE19792900887 priority patent/DE2900887A1/de
Priority to PT69067A priority patent/PT69067A/pt
Publication of ES471572A1 publication Critical patent/ES471572A1/es
Priority to FR7902226A priority patent/FR2434819A1/fr
Priority to IT7919807A priority patent/IT7919807A0/it
Priority to BE193723A priority patent/BE874483A/xx
Priority to CA324,314A priority patent/CA1106285A/en
Priority to SE7903762A priority patent/SE7903762L/xx
Priority to DK180379A priority patent/DK180379A/da
Priority to CH477779A priority patent/CH642085A5/de
Priority to JP54064871A priority patent/JPS6026376B2/ja
Priority to GB7918174A priority patent/GB2024622B/en
Priority to MX798029U priority patent/MX5596E/es
Priority to IL57721A priority patent/IL57721A/xx
Priority to FI792128A priority patent/FI792128A/fi
Priority to IS2495A priority patent/IS2495A7/is
Priority to NL7905251A priority patent/NL7905251A/nl
Priority to LU81464A priority patent/LU81464A1/fr
Priority to NZ190933A priority patent/NZ190933A/xx
Priority to MA18709A priority patent/MA18512A1/fr
Priority to HU79CO371A priority patent/HU179689B/hu
Priority to NO792260A priority patent/NO792260L/no
Priority to ZA793398A priority patent/ZA793398B/xx
Priority to OA56841A priority patent/OA06288A/xx
Priority to PL1979216905A priority patent/PL124244B1/pl
Priority to CS794777A priority patent/CS215008B2/cs
Priority to AT0471479A priority patent/AT371715B/de
Priority to EG415/79A priority patent/EG14496A/xx
Priority to RO7998089A priority patent/RO76833A/ro
Priority to AU48764/79A priority patent/AU4876479A/en
Priority to DD79214207A priority patent/DD144719A5/de
Priority to PH22755A priority patent/PH14338A/en
Priority to IE1274/79A priority patent/IE48526B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un procedimiento de obtención de fracción polar natural con actividad anti-psoriática, por extracción de los rizomas y hojas de Dryopteris crassirhizoma, Polypodium vulgare, Linn, Polypodium leucotomos, Phlebodium Decumanum J. Smith, Polypodium decumanun, Cynthea taiwaniana y rizomas de Polypodium aureum Linn, y Polypodium triseriales, caracterizado porque se cortan los rizomas en trozos de 2 - 3 cm. y se someten los trozos de rizoma y las hojas a una operación de secado continuo, a una temperatura no superior a 70ºC., moliéndose posteriormente el material seco con una humedad residual inferior al 8% para formar partículas de hasta 2 mm. de diámetro, con una densidad aproximada entre 0.1 a 0.80, se produce la extracción con un disolvente con una constante dieléctrica comprendida entre 1,890 y 9.08., se evapora el disolvente y se purifica el residuo, recogiéndose el residuo semi-sólido del extracto en n-hexano/agua (10:4), dejándolo en reposo durante la noche en un separador y separando la fase acuosa, de tal manera que la solución acuosa se hace pasar por una resina intercambiadora y se agrega Ca (OH2) hasta neutralizar la solución sobre la cual se agregan proporciones de carbón activado hasta que la solución es clarificada, procediéndose a su evaporación hasta 1/100 del original y precipitándose con alcohol absoluto de tal manera que el precipitado se filtra por succión y las aguas se evaporan de nuevo para obtener una segunda porción de polvo, la cual se seca al vacío hasta que queda un sólido muy blanco.
ES471572A 1978-07-07 1978-07-07 Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica Expired ES471572A1 (es)

Priority Applications (35)

Application Number Priority Date Filing Date Title
ES471572A ES471572A1 (es) 1978-07-07 1978-07-07 Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica
AR274971A AR230188A1 (es) 1978-07-07 1978-12-27 Procedimiento de obtencion de fraccion polar natural con actividad antipsoriatica
GR57991A GR65334B (en) 1978-07-07 1978-12-28 Method for the receipt of polar fraction which have an efficacity against to psoriasis
DE19792900887 DE2900887A1 (de) 1978-07-07 1979-01-11 Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
PT69067A PT69067A (en) 1978-07-07 1979-01-12 Process for obtaining a natural polar fraction having antipsoriatic activity
FR7902226A FR2434819A1 (fr) 1978-07-07 1979-01-29 Fraction polaire naturelle, utile notamment comme antipsoriasique, et son procede de preparation
IT7919807A IT7919807A0 (it) 1978-07-07 1979-02-01 Procedimento per l'ottenimentodi una frazione polare presentante una attivita' antipsoriasica.
BE193723A BE874483A (fr) 1978-07-07 1979-02-27 Procede d'obtention de fraction polaire naturelle dotee d'activite anti-psoriasique
CA324,314A CA1106285A (en) 1978-07-07 1979-03-28 Process for obtaining a natural polar fraction having anti-psoriatic activity
SE7903762A SE7903762L (sv) 1978-07-07 1979-04-27 Sett for erhallande av en naturlig polar fraktion med antipsoriatisk effekt
DK180379A DK180379A (da) 1978-07-07 1979-05-02 Fremgangsmaade til udvinding af en naturlig polaer fraktion af forskellige bregnearter
CH477779A CH642085A5 (de) 1978-07-07 1979-05-22 Verfahren zur gewinnung der polaren fraktion mit antipsoriatischer wirksamkeit eines extraktes aus farnpflanzen sowie ein gemaess diesem verfahren hergestelltes praeparat.
JP54064871A JPS6026376B2 (ja) 1978-07-07 1979-05-24 抗乾癬活性物質およびその製法
GB7918174A GB2024622B (en) 1978-07-07 1979-05-24 Anti-psoriatic fern extracts
MX798029U MX5596E (es) 1978-07-07 1979-05-29 Procedimiento para la obtencion de un extracto vegetal con actividad antipsoriatica
IL57721A IL57721A (en) 1978-07-07 1979-07-04 Process for obtaining a natural fraction having anti-psoriatic activity
LU81464A LU81464A1 (fr) 1978-07-07 1979-07-05 Procede d'obtention d'une fraction polaire naturelle dotee d'activite anti-psoriasique
FI792128A FI792128A (fi) 1978-07-07 1979-07-05 Foerfarande foer framstaellning av en naturlig polaer fraktion med antipsoriatisk verkan
IS2495A IS2495A7 (is) 1978-07-07 1979-07-05 Aðferð til þess, að ná útjaðrahlutum jurta, sem hafa læknandi áhrif á húðsjúkdóma, (Psoriasis)
NL7905251A NL7905251A (nl) 1978-07-07 1979-07-05 Werkwijze voor het winnen van een natuurstof met anti- psoriatische werking alsmede farmaceutisch preparaat op basis daarvan.
AT0471479A AT371715B (de) 1978-07-07 1979-07-06 Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
OA56841A OA06288A (fr) 1978-07-07 1979-07-06 Procédé d'obtention de fraction polaire naturelle dotée d'activité anti-psoriasique.
CS794777A CS215008B2 (en) 1978-07-07 1979-07-06 Method of gaining natural polar fractions with antipsoriatic activity
HU79CO371A HU179689B (en) 1978-07-07 1979-07-06 Pharmaceutical composition against psoriasis and process for preparing such composition
NO792260A NO792260L (no) 1978-07-07 1979-07-06 Fremgangsmaate ved utvinning av en naturlig forekommende polar fraksjon med antipsoriatisk virkning
ZA793398A ZA793398B (en) 1978-07-07 1979-07-06 Process for obtaining a natural polar fraction having anti-psoriatic activity
NZ190933A NZ190933A (en) 1978-07-07 1979-07-06 Anti-psoriatic product extracted from leaves and rhizomes of ferns
PL1979216905A PL124244B1 (en) 1978-07-07 1979-07-06 Method of isolation of polar fractions of natural substances of antipsoriatic activity
MA18709A MA18512A1 (fr) 1978-07-07 1979-07-06 Procede d'obtention de fraction polaire naturelle dotee d'activite anti-psoriasique
RO7998089A RO76833A (ro) 1978-07-07 1979-07-07 Procedeu pentru obtinerea unei fractiuni polare naturale care are activitate antipsoriatica
EG415/79A EG14496A (en) 1978-07-07 1979-07-07 Process for obtaining a natural polar fraction having antipsoriatic activity
AU48764/79A AU4876479A (en) 1978-07-07 1979-07-09 Plant extraction for treatment of psoriasis
DD79214207A DD144719A5 (de) 1978-07-07 1979-07-09 Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
PH22755A PH14338A (en) 1978-07-07 1979-07-09 Process for obtaining a natural polar fraction having antipsoriatic activity
IE1274/79A IE48526B1 (en) 1978-07-07 1979-08-08 Natural polar fraction having ant-psoriatic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES471572A ES471572A1 (es) 1978-07-07 1978-07-07 Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica

Publications (1)

Publication Number Publication Date
ES471572A1 true ES471572A1 (es) 1979-01-16

Family

ID=8476458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES471572A Expired ES471572A1 (es) 1978-07-07 1978-07-07 Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica

Country Status (35)

Country Link
JP (1) JPS6026376B2 (es)
AR (1) AR230188A1 (es)
AT (1) AT371715B (es)
AU (1) AU4876479A (es)
BE (1) BE874483A (es)
CA (1) CA1106285A (es)
CH (1) CH642085A5 (es)
CS (1) CS215008B2 (es)
DD (1) DD144719A5 (es)
DE (1) DE2900887A1 (es)
DK (1) DK180379A (es)
EG (1) EG14496A (es)
ES (1) ES471572A1 (es)
FI (1) FI792128A (es)
FR (1) FR2434819A1 (es)
GB (1) GB2024622B (es)
GR (1) GR65334B (es)
HU (1) HU179689B (es)
IE (1) IE48526B1 (es)
IL (1) IL57721A (es)
IS (1) IS2495A7 (es)
IT (1) IT7919807A0 (es)
LU (1) LU81464A1 (es)
MA (1) MA18512A1 (es)
MX (1) MX5596E (es)
NL (1) NL7905251A (es)
NO (1) NO792260L (es)
NZ (1) NZ190933A (es)
OA (1) OA06288A (es)
PH (1) PH14338A (es)
PL (1) PL124244B1 (es)
PT (1) PT69067A (es)
RO (1) RO76833A (es)
SE (1) SE7903762L (es)
ZA (1) ZA793398B (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068163A1 (es) * 1994-05-06 1995-04-01 Esp Farmaceuticas Centrum Sa Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
ES2124675A1 (es) * 1997-07-30 1999-02-01 Helsint S A L Helechos Interna "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".
WO1999006058A1 (es) * 1997-07-30 1999-02-11 Helsint, S.A.L. Fracciones hidrosolubles de phlebodium decumanum y su empleo como complemento nutricional en pacientes de sida y cancer
ES2137900A1 (es) * 1998-06-02 1999-12-16 Helsint S A L Empleo de formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum como complemento nutricional en el tratamiento del sindrome caquectico en pacientes oncologicos.

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES470204A1 (es) * 1978-05-24 1979-01-01 Conrad Ltd Procedimiento de obtencion de terpenos naturales con activi-dad antipsoriatica
ES8104315A1 (es) * 1980-04-02 1981-04-16 Conrad Ltd Un procedimiento de obtencion de un extracto de las fraccio-nes polares de los helechos de la familia polypodiaceae.
NO150880C (no) * 1981-06-01 1985-01-16 Borregaard Ind Nye aza-krone-etere og anvendelse derav
EP0364442B1 (en) * 1987-12-23 1993-03-03 Psoricur Ltd. Therapeutical compositions against psoriasis
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
JPH0633820U (ja) * 1992-10-13 1994-05-06 マルヤス機械株式会社 ローラコンベア
ATE222112T1 (de) * 1994-05-06 2002-08-15 Esp Farmaceuticas Centrum Sa Pharmazeutische zusammensetzung enthaltend farnextrakt(e) zur behandlung von neurodegenerativen krankheiten.
FR2863163B1 (fr) * 2003-12-04 2006-02-24 Oreal Composition, notamment cosmetique, comprenant des extraits de fougere et de nacre
FR2876032B1 (fr) * 2004-10-05 2008-10-31 Greentech Sa Sa Utilisation d'extraits de fougeres dans des preparations cosmetiques ou dermatologiques
US20060246115A1 (en) * 2005-03-04 2006-11-02 Ricardo Rueda Nutritional products for ameliorating symptoms of rheumatoid arthritis
AT515350A1 (de) * 2014-02-10 2015-08-15 Christoph Dipl Ing Brandstätter Verfahren zur Herstellung eines Konzentrats eines Holzschutzmittels, damit hergestelltes Konzentrat und Verfahren zur Behandlung von Holz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB256768A (en) * 1925-07-17 1926-08-19 Francesco Fumarola Process for extraction of the active biological principles from the ether extract of male fern
US3395223A (en) * 1965-05-13 1968-07-30 Carter Wallace Fern extract for treating gastric ulcers
FR2395266A1 (fr) * 1977-06-23 1979-01-19 Suffren Ste Parti Brevets -lactone monomeres et leurs polymeres, sels et derives, utilisables notamment comme colorants, adjuvants de tannage et medicaments
JPS5464870A (en) * 1977-10-21 1979-05-25 Gte Laboratories Inc Solid state microwave power supply for electrodeless light source

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068163A1 (es) * 1994-05-06 1995-04-01 Esp Farmaceuticas Centrum Sa Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
ES2124675A1 (es) * 1997-07-30 1999-02-01 Helsint S A L Helechos Interna "formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum, y su uso en el tratamiento del sindrome caquectico en enfermos de sida".
WO1999006058A1 (es) * 1997-07-30 1999-02-11 Helsint, S.A.L. Fracciones hidrosolubles de phlebodium decumanum y su empleo como complemento nutricional en pacientes de sida y cancer
ES2137900A1 (es) * 1998-06-02 1999-12-16 Helsint S A L Empleo de formulaciones a base de una fraccion hidrosoluble de phlebodium decumanum como complemento nutricional en el tratamiento del sindrome caquectico en pacientes oncologicos.

Also Published As

Publication number Publication date
JPS5511570A (en) 1980-01-26
JPS6026376B2 (ja) 1985-06-24
GB2024622A (en) 1980-01-16
HU179689B (en) 1982-11-29
FR2434819B1 (es) 1982-07-09
PL216905A1 (es) 1980-04-21
NL7905251A (nl) 1980-01-09
AU4876479A (en) 1980-01-10
NZ190933A (en) 1982-11-23
DD144719A5 (de) 1980-11-05
IL57721A (en) 1983-07-31
IL57721A0 (en) 1979-11-30
FI792128A (fi) 1980-01-08
PH14338A (en) 1981-05-29
ATA471479A (de) 1982-12-15
FR2434819A1 (fr) 1980-03-28
NO792260L (no) 1980-01-08
IE48526B1 (en) 1985-02-20
OA06288A (fr) 1981-06-30
GB2024622B (en) 1983-03-30
AT371715B (de) 1983-07-25
IT7919807A0 (it) 1979-02-01
BE874483A (fr) 1979-06-18
CA1106285A (en) 1981-08-04
AR230188A1 (es) 1984-03-01
RO76833A (ro) 1981-05-30
IS2495A7 (is) 1981-02-06
ZA793398B (en) 1981-07-29
SE7903762L (sv) 1980-01-08
GR65334B (en) 1980-08-14
PT69067A (en) 1979-02-01
CH642085A5 (de) 1984-03-30
MX5596E (es) 1983-11-04
EG14496A (en) 1984-03-31
LU81464A1 (fr) 1980-04-21
IE791274L (en) 1980-01-07
CS215008B2 (en) 1982-06-25
PL124244B1 (en) 1983-01-31
DK180379A (da) 1980-01-08
DE2900887A1 (de) 1980-01-24
MA18512A1 (fr) 1980-04-01

Similar Documents

Publication Publication Date Title
ES471572A1 (es) Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica
AU4734279A (en) Sewage disposal system
AU528026B2 (en) Outlet assembly for lavatory basin
BE877788A (fr) Marteau perforateur motorise
AU4551279A (en) Power steering valve
GB2018702A (en) Auxiliary control of fluid operated steering apparatus forships boats and the like
AU7545481A (en) Distillation of waste water
IT1099396B (it) Metodo e dispositivo per migliorare la distribuzione di acqua da un anmaffiatore azionato a bassa pressione
AU534843B2 (en) Water dilutable alkyd and acrylate lacquers
IT7919640A0 (it) Impianto di depurazione di acque di scarico secondo il procedimento con i fanghi attivi.
SE7903761L (sv) Sett for framstellning av naturliga terpener med antipsoriatisk effekt
BE876731A (fr) Installation pour le filtrage fin d'eau ou d'eau usee
HU186354B (en) Hydraulic arrangement for exerting large pull force
MY8500364A (en) Pipe shearing ram assembly for blow out preventer
ATA361979A (de) Tastatur zur betaetigung von druckschaltern
GB2043304B (en) Pilot operated relief valve
AU5217179A (en) Power steering valve
GB2022446B (en) Removing alcohol from waste gas
AU536537B2 (en) Pilot operated irrigation valve
JPS5211643A (en) Method of treating colloidal resin waste fluid
JPS5442623A (en) Operating method for soundproof transformer
JPS54164347A (en) Waste water disposal plant
JPS5599394A (en) Sewage filth disposal plant
AU522671B2 (en) Sludge thickening
RO82048A2 (ro) Procedeu de extractie a unui extract de alcaloizi din planta vinca minor l